Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany

This publication has 20 references indexed in Scilit:

• Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
  New England Journal of Medicine, 2005
• Relative Importance of Borderline and Elevated Levels of Coronary Heart Disease Risk Factors
  Annals of Internal Medicine, 2005
• Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering study
  The American Journal of Cardiology, 2004
• Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
  Circulation, 2004
• British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary
  BMJ, 2004
• Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?
  The American Journal of Cardiology, 2004
• European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
  European Journal of Preventive Cardiology, 2003
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries
  The Lancet, 2001
• High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport
  Atherosclerosis, 1996